High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia
- 1 August 1987
- journal article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 65 (16) , 773-780
- https://doi.org/10.1007/bf01743253
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and NeutropeniaNew England Journal of Medicine, 1986
- Adult Respiratory Distress Syndrome in Patients with Severe NeutropeniaNew England Journal of Medicine, 1986
- Age Adapted Induction and Intensified Consolidation Therapy in Acute Myelogenous LeukemiaOncology Research and Treatment, 1986
- Septikämien bei Leukämien und malignen LymphomenJournal of Molecular Medicine, 1985
- Hochdosis-Cytosinarabinosid in der Behandlung rezidivierter oder refraktärer akuter myeloischer LeukämienOncology Research and Treatment, 1985
- Hochdosierte Cytarabin-Behandlung bei akuten Leukämien und Meningiosis Leucaemica: Klinik und PharmakokinetikOncology Research and Treatment, 1985
- The in vitro and in vivo activity of ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- High-dose cytosine arabinoside in multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1984
- Bacteremia due to Staphylococcus aureus in Patients with Cancer: Report on 45 Cases in Adults and Review of the LiteratureClinical Infectious Diseases, 1982